Related references
Note: Only part of the references are listed.MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
Stian Knappskog et al.
Oncotarget (2015)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Racial and Regional Disparities in Lung Cancer Incidence
J. Michael Underwood et al.
CANCER (2012)
The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians
Stian Knappskog et al.
CANCER CELL (2011)
MDM2 SNP309 Contributes to Non-Small Cell Lung Cancer Survival in Chinese
Jing Dong et al.
MOLECULAR CARCINOGENESIS (2011)
Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore
Hui Wan Chua et al.
BMC CANCER (2010)
The p53 orchestra: Mdm2 and Mdmx set the tone
Mark Wade et al.
TRENDS IN CELL BIOLOGY (2010)
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
Fiona E. M. Paulin et al.
BMC CANCER (2008)
MDM2 SNP309 and cancer risk: a combined analysis
Stefan Wilkening et al.
CARCINOGENESIS (2007)
MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling
Marijke Wasielewski et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
MDM2 polymorphism, survival, and histology in early-stage non-small-cell lung cancer
Rebecca Suk Heist et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Combined effects of p73 and MDM2 polymorphisms on the risk of lung cancer
Hee Jung Jun et al.
MOLECULAR CARCINOGENESIS (2007)
MDM2 SNP309 accelerates colorectal tumour formation in women
Gareth L. Bond et al.
JOURNAL OF MEDICAL GENETICS (2006)
MDM2 309T>G polymorphism and risk of lung cancer in a Korean population
Sun Ha Park et al.
LUNG CANCER (2006)
Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer
Helge Lind et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Association of breast cancer outcome with status of p53 and MDM2 SNP309
Brenda J. Boersma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
Gareth L. Bond et al.
CANCER RESEARCH (2006)
Exploring SNP-SNP interactions and colon cancer risk using polymorphism interaction analysis
JE Goodman et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population
ZB Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements
B Saville et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
